We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+0.23%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$36.6B
AUM Growth
+$542M
(+1.5%)
Cap. Flow
+$871M
Cap. Flow
% of AUM
2.38%
Top 10 Holdings %
Top 10 Hldgs %
24.82%
Holding
990
New
258
Increased
273
Reduced
319
Closed
82
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AA.PRB
Alcoa Inc
AA.PRB
|
+$248M |
| 2 |
Oracle
ORCL
|
+$188M |
| 3 |
Qualcomm
QCOM
|
+$139M |
| 4 |
Meta Platforms (Facebook)
META
|
+$130M |
| 5 |
Amazon
AMZN
|
+$124M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPG Industries
PPG
|
+$666M |
| 2 |
Gilead Sciences
GILD
|
+$95.2M |
| 3 |
LVLT
Level 3 Communications Inc
LVLT
|
+$56.1M |
| 4 |
CCI.PRA
Crown Castle International Corp.
CCI.PRA
|
+$47.6M |
| 5 |
Motorola Solutions
MSI
|
+$45.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.55% |
| 2 | Healthcare | 12.56% |
| 3 | Financials | 12.39% |
| 4 | Consumer Discretionary | 11.97% |
| 5 | Communication Services | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FRP
526
DELISTED
Fairpoint Communications, Inc.
FRP
| $1.2M | ﹤0.01% |
65,902
-128,194
| -66% | -$2.47M |
|
|
VRTU
527
DELISTED
Virtusa Corporation
VRTU
| $1.18M | ﹤0.01% |
22,954
-1,021
| -4% | -$45.4K |
|
|
WPG
528
DELISTED
Washington Prime Group Inc.
WPG
| $1.16M | ﹤0.01% |
9,499
-2,732
| -22% | -$360K |
|
529
Cigna
CI
$74.6B
| $1.15M | ﹤0.01% |
7,112
| – | – |
|
530
Fortinet
FTNT
$117B
| $1.15M | ﹤0.01% |
139,170
-18,310
| -12% | -$142K |
|
531
Jones Lang LaSalle
JLL
$16.7B
| $1.15M | ﹤0.01% |
6,719
-295
| -4% | -$49.8K |
|
532
Cognex
CGNX
$11.3B
| $1.12M | ﹤0.01% |
46,540
-2,064
| -4% | -$50.7K |
|
|
DNKN
533
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $1.07M | ﹤0.01% |
19,518
-670
| -3% | -$34.7K |
|
534
Blackbaud
BLKB
$2.08B
| $1.07M | ﹤0.01% |
18,793
+7,493
| +66% | +$391K |
|
|
CMD
535
DELISTED
Cantel Medical Corporation
CMD
| $1.06M | ﹤0.01% |
19,787
-881
| -4% | -$42.9K |
|
|
FRC
536
DELISTED
First Republic Bank
FRC
| $1.03M | ﹤0.01% |
16,351
+4,402
| +37% | +$266K |
|
537
Gartner
IT
$11.7B
| $1.01M | ﹤0.01% |
11,745
+721
| +7% | +$61.8K |
|
538
Tyler Technologies
TYL
$12.8B
| $984K | ﹤0.01% |
7,608
-338
| -4% | -$42K |
|
|
EVHC
539
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $964K | ﹤0.01% |
8,159
+461
| +6% | +$52.4K |
|
540
Brunswick
BC
$5.28B
| $943K | ﹤0.01% |
18,548
-826
| -4% | -$43.2K |
|
541
Icon
ICLR
$12.7B
| $923K | ﹤0.01% |
13,720
-3,341
| -20% | -$225K |
|
542
SPS Commerce
SPSC
$2.64B
| $921K | ﹤0.01% |
28,002
-1,248
| -4% | -$42K |
|
543
Acuity Brands
AYI
$10.8B
| $915K | ﹤0.01% |
5,084
+284
| +6% | +$49.8K |
|
544
Jazz Pharmaceuticals
JAZZ
$16.7B
| $897K | ﹤0.01% |
5,095
-226
| -4% | -$40.6K |
|
545
BlackRock Floating Rate Income Strategies Fund
FRA
$385M
| $886K | ﹤0.01% |
65,559
+15,559
| +31% | +$215K |
|
546
Carter's
CRI
$1.47B
| $880K | ﹤0.01% |
8,274
-2,735
| -25% | -$274K |
|
547
HealthStream
HSTM
$840M
| $876K | ﹤0.01% |
28,810
+3,199
| +12% | +$91.6K |
|
548
PRA Group
PRAA
$755M
| $866K | ﹤0.01% |
13,896
-619
| -4% | -$35.7K |
|
549
Marcus & Millichap
MMI
$1.19B
| $864K | ﹤0.01% |
18,723
-661
| -3% | -$28.2K |
|
550
H&R Block
HRB
$5.86B
| $856K | ﹤0.01% |
28,871
-1,504
| -5% | -$47.2K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2015 Portfolio in Review
As of Q2 2015, Loomis, Sayles & Company held 990 positions worth $36.6B, up 1.5% from $36.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Loomis, Sayles & Company's Q2 2015 filing shows 258 new, 273 increased, 319 reduced and 82 closed positions. Its largest new stake was Alexion Pharmaceuticals: 419,324 shares worth $75.8M. The largest sale was PPG Industries, an estimated $666M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Loomis, Sayles & Company's largest Q2 2015 buy was Alexion Pharmaceuticals: 419,324 shares worth $75.8M.
- Loomis, Sayles & Company added most to Alcoa Inc in Q2 2015, an estimated $248M increase.
- Loomis, Sayles & Company's biggest Q2 2015 reduction was PPG Industries, cutting an estimated $666M.
- Loomis, Sayles & Company fully exited AOL INC COMMON STOCK in Q2 2015, selling an estimated $40.1M.
- Loomis, Sayles & Company's ten largest holdings make up 25% of its $36.6B portfolio in Q2 2015.
- Loomis, Sayles & Company opened 258 new positions and closed 82 in Q2 2015.
- Loomis, Sayles & Company's portfolio value rose 1.5% quarter-over-quarter to $36.6B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2015, filed 14 Aug 2015.